Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Holguín A, Norman F, Martín L, Mateos ML, Chacón J, López-Vélez R, Pérez-Molina JA.
Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs.
Clinical and Vaccine Immunology . 20(8): 1197-1202. Nº de citas: 21
-
Savini H, Gautret P, Gaudart J, Field V, Castelli F, López-Vélez R, Lim PL, Shaw M, von Sonnenburg F, Loutan L, Simon F.
Travel associated Diseases, Indian Ocean Islands, 1997-2010
EMERGING INFECTIOUS DISEASES . 19(8): 1297-1301. Nº de citas: 19
-
Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, SPRING-1 Team.
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.
AIDS . 27(11): 1771-1778. Nº de citas: 145
-
Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H, BENCHMRK Study Teams.
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
LANCET INFECTIOUS DISEASES . 13(7): 587-596. Nº de citas: 114
-
Casado JL.
Liver Toxicity in HIV-Infected Patients Receiving Novel Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors Etravirine and Rilpivirine
AIDS REVIEWS . 15(3): 139-145. Nº de citas: 17
-
Kaulich-Bartz J, Dam W, May MT, Lederberger B, Widmer U, Phillips AN, Grabar S, Mocroft A, Vilaro J, van Sighem A, Moreno S, Dabis F, Monforte AD, Teira R, Ingle SM, Sterne JA.
Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies
AIDS . 27(10): 1641-1655. Nº de citas: 9
-
Sainz T, Serrano-Villar S, Díaz L, González Tomé MI, Gurbindo MD, de José MI, Mellado MJ, Ramos JT, Zamora J, Moreno S, Muñoz-Fernández MA.
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults
AIDS . 27(9): 1513-1516. Nº de citas: 142
-
Díez-Aguilar M, Ruiz-Garbajosa P, Fernández-Olmos A, Guisado P, Del Campo R, Quereda C, Cantón R, Meseguer MA.
Non-diphtheriae Corynebacterium species: an emerging respiratory pathogen
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 32(6): 769-772. Nº de citas: 66
-
Gasch O, Camoez M, Domínguez MA, Padilla B, Pintado V, Almirante B, Lepe JA, Lagarde M, Ruiz de Gopegui E, Martínez JA, Montejo M, Torre-Cisneros J, Arnáiz A, Goenaga MA, Benito N, Rodríguez-Baño J, Pujol M.
Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 68(6): 1423-1430. Nº de citas: 42
-
Berenguer J, Alvarez-Pellicer J, Carrero A, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Tural C, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Barquilla E, Bellón JM, González-García J.
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus
JOURNAL OF HEPATOLOGY . 58(6): 1104-1112. Nº de citas: 23
-
Casado JL, Iglesias V, del Palacio M, Marín A, Perez-Elías MJ, Moreno A, Moreno S.
Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV . 25(12): 1599-1603. Nº de citas: 5
-
Lo B, Grady C, Working Group on Ethics of the International AIDS Society.
Ethical considerations in HIV cure research: points to consider
Current Opinion in HIV and AIDS . 8(3): 243-249. Nº de citas: 76
-
Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD.
Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Study(a)
JOURNAL OF INFECTIOUS DISEASES . 207(9): 1359-1369. Nº de citas: 259
-
Rosinska M, Marzec-Bogustawska A, Janiec J, Smolen-Dzirba J, Wasik T, Gniewosz J, Zalewska M, Murphy G, McKinney E, Porter K, CASCADE Collaboration In Eurocoord.
High Percentage of Recent HIV Infection Among HIV-Positive Individuals Newly Diagnosed at Voluntary Counseling and Testing Sites in Poland
AIDS RESEARCH AND HUMAN RETROVIRUSES . 29(5): 805-813. Nº de citas: 20
-
Arnalich-Montiel F, Lorenzo-Morales J, Irigoyen C, Morcillo-Laiz R, López-Vélez R, Muñoz-Negrete F, Piñero JE, Valladares B.
Co-isolation of Vahlkampfia and Acanthamoeba in Acanthamoeba-Like Keratitis in a Spanish Population
CORNEA . 32(5): 608-614. Nº de citas: 20
-
Cobo J, Lora-Tamayo J, Euba G, Jover-Sáenz A, Palomino J, del Toro MD, Rodríguez-Pardo D, Riera M, Ariza J.
Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE . 76(1): 93-98. Nº de citas: 11
-
Suárez-García I, Jarrín I, Iribarren JA, López-Cortés LF, Lacruz-Rodrigo J, Masiá M, Gómez-Sirvent JL, Hernández-Quero J, Vidal F, Alejos-Ferreras B, Moreno S, Del Amo J.
Incidence and risk factors of AIDS-defining cancers in a cohort of HIV-positive adults: Importance of the definition of incident cases
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 31(5): 304-312. Nº de citas: 8
-
Monge S, Alejos B, Dronda F, Del Romero J, Iribarren JA, Pulido F, Rubio R, Miró JM, Gutierrez F, Del Amo J.
Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain
HIV MEDICINE . 14(5): 273-283. Nº de citas: 48